Search Results - Haiqing Dai
- Showing 1 - 3 results of 3
-
1
Model‐informed drug development supporting the approval of the avelumab flat‐dose regimen in patients with advanced renal cell carcinoma by Joanna C. Masters, Akash Khandelwal, Alessandra diPietro, Haiqing Dai, Satjit Brar
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma by Justin J. Wilkins, Brigitte Brockhaus, Haiqing Dai, Yulia Vugmeyster, Joleen T. White, Satjit Brar, Carlo L. Bello, Berend Neuteboom, Janet R. Wade, Pascal Girard, Akash Khandelwal
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab by Nadia Terranova, Jonathan French, Haiqing Dai, Matthew Wiens, Akash Khandelwal, Ana Ruiz‐Garcia, Juliane Manitz, Anja vonHeydebreck, Mary Ruisi, Kevin Chin, Pascal Girard, Karthik Venkatakrishnan
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book